Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma
Phase 1
Terminated
- Conditions
- Advanced Solid TumorAdvanced Lymphoma
- Interventions
- First Posted Date
- 2020-10-30
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Stingthera, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT04609579
- Locations
- 🇺🇸
Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States
🇺🇸Tennessee Oncology, Nashville, Tennessee, United States
🇺🇸Florida Cancer Specialists, Sarasota, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath